- Lobbying
- Lobbying by Cauthen Forbes & Williams on behalf of Amgen, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeff Forbes | Staff Director, Senate Finance Committee Chief of Staff, Senator Max Baucus Deputy Asst, Special Asst, Deputy Director EOP |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare Coverage and reimbursement issues pertaining to dialysis products and bone densitromety (DXA) and issues dealing with ASP+6 and 340B; issues related to Part D debate issues related to the Prescription Drug User Fee Act; issues related to Medicaid coverage..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate